Immunotherapy prolongs survival in recurrent, persistent or metastatic cervical cancer

Lugano, Switzerland, 18 September 2021 – The addition of immunotherapy to standard first-line treatment extends survival by eight months for patients with recurrent, persistent or metastatic cervical cancer, according to late breaking results from the KEYNOTE-826 study presented at the ESMO Congress 2021. (1)  Credit: ESMO Lugano, Switzerland, 18 September 2021 – The addition of immunotherapy to standard first-line treatment extends survival by eight...

Biotechnology Can Fight Climate Change—But Trade Negotiators Need to Act | Opinion – Newsweek

Over 800 million people around the world don't have enough to eat. Tragically, that number has only increased amid COVID-19, likely foreshadowing a perilous course ahead as we confront another, equally grave crisis.According to...

Infants exposed to domestic violence have poorer cognitive development

COLUMBIA, Mo. – While assessing a pregnant woman with premature labor in 1983, Linda Bullock noticed bruises on the woman. When she asked what happened, the woman told Bullock a refrigerator had fallen on...

Ginkgo Bioworks Rings a Bell in NYC

With the children of the company’s co-founders right up front, the Ginkgo Bioworks team rang the bell of the New York Stock Exchange this morning, taking the synthetic biology company public. The synthetic biology...

Uncovering the Secrets of AAV for Improved Cell and Gene Therapies

REGISTER NOW Broadcast Date: October 5, 2021Time: 8:00 am PT, 11:00 am ET, 17:00 CET We are all keenly aware that viruses can negatively impact our lives, but what about viruses that shape our existence...

Agricultural biotechnology center being built in Almeria – hortidaily.com

Kimitec, a company dedicated to researching, developing, and commercializing biopesticides, prebiotic biostimulants, and probiotics, has invested 50 million euros in expanding its plant in the Almeria town of Vicar, which will become the largest...

Scientists examine kids’ unique immune systems as more fall victim to covid

Eighteen months into the covid-19 pandemic, with the delta variant fueling a massive resurgence of disease, many hospitals are hitting a heartbreaking new low. They're now losing babies to the coronavirus. The first reported...

GammaDelta Therapeutics initiates first-in-human phase 1 trial of GDX012 for the treatment of acute...

GammaDelta Therapeutics Ltd. (GDT), a biotechnology company pioneering the discovery and development of allogeneic gamma delta T cell therapies for cancer, today announced that it has initiated a first-in-human Phase I clinical trial evaluating...

Jaws; or, how an African ray-finned fish is helping to rethink the fundamentals of...

AMHERTS, Mass. – A family of fishes, called the cichlids, in Africa’s Lake Malawi is helping researchers at the University of Massachusetts Amherst to refine our understanding of how evolution works. Credit: Craig Albertson AMHERTS, Mass....

Inflammasome Therapeutics Takes On Sustained Drug Delivery

Inflammasome has recently been awarded a $1.3 million grant from the Bill and Melinda Gates Foundation to develop dual bioerodible sustained-release implants that combine drugs for HIV prevention and birth control. The implant will...